Probiotic for early Alzheimer's: safety and memory benefits
Part of Brain & nervous system, Mental health clinical trials.
This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 55 and 85 years old.
- You have been diagnosed with early-stage Alzheimer's disease or mild cognitive impairment.
- A PET scan has shown amyloid buildup in your brain (a key sign of Alzheimer's).
- You do not have other serious brain conditions, uncontrolled health issues, or recent major changes to Alzheimer's medications.
- You are not taking medications that affect the gut bacteria, like certain antibiotics, within the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called BEY2153 for people with early Alzheimer's disease (mild cognitive impairment or mild dementia). The goal is to see if it is safe and slows down memory decline.
This study tests whether daily probiotics (beneficial bacteria) can help people with mild Alzheimer's disease. It's an early-phase trial to see if probiotics are safe and might improve thinking and memory.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
This trial tests whether a daily probiotic called Lacticaseibacillus paracasei PS23 can help improve thinking and memory in adults aged 50 to 85 who feel their memory is slipping but do not have dementia or Alzheimer's disease.
This study tests whether a precision probiotic supplement can help people with mild cognitive impairment (MCI) who also have signs of amyloid buildup in the brain. If you qualify, you would be randomly assigned to take the probiotic or a placebo for a period of time.
Hear when a new Early Alzheimer's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.